Low Aβ42 levels, high concentrations of t-tau and p-ta, and the ratio of tau/Aβ42 help to discriminate AD from healthy controls and other dementias (Shaw et al., 2009; Casoli et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.